UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 150

Sortiert nach

Human Angiopoietin-like Protein 3/ANGPTL3 Antibodies: Adding to the Armamentarium in the Management of Dyslipidemia

Journal of cardiovascular pharmacology, 2021-11, Vol.78 (5), p.e631

Wiggins, Barbara S

2021

Volltextzugriff (PDF)

Select Drug-Drug Interactions With Direct Oral Anticoagulants: JACC Review Topic of the Week

Journal of the American College of Cardiology, 2020-03, Vol.75 (11), p.1341

2020

Volltextzugriff (PDF)

2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee

Journal of the American College of Cardiology, 2020-08, Vol.76 (5), p.594

2020

Volltextzugriff (PDF)

2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents

Journal of the American College of Cardiology, 2018-12, Vol.72 (25), p.3332-3365

2018

Volltextzugriff (PDF)

Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association

Circulation (New York, N.Y.), 2016-11, Vol.134 (21), p.e468-e495

2016

Volltextzugriff (PDF)

Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care

Pharmacotherapy, 2022-05, Vol.42 (5), p.428-438

2022

Volltextzugriff (PDF)

Select drug-drug interactions with colchicine and cardiovascular medications: A review

The American heart journal, 2022-10, Vol.252, p.42-50

2022

Volltextzugriff (PDF)

Reduced Anticoagulant Effect of Dabigatran in a Patient Receiving Concomitant Phenytoin

Pharmacotherapy, 2016-02, Vol.36 (2), p.e5-e7

2016

Volltextzugriff (PDF)

2023 Atrial Fibrillation Guideline-at-a-Glance

Journal of the American College of Cardiology, 2024-01, Vol.83 (1), p.280-284

2024

Volltextzugriff (PDF)

Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review

Advances in therapy, 2020-02, Vol.37 (2), p.656-670

2020

Volltextzugriff (PDF)

Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Weighing ≥ 120 Kilograms versus 60–120 Kilograms

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2021-09, Vol.21 (5), p.545-551

2021

Volltextzugriff (PDF)

Evolocumab: Considerations for the Management of Hyperlipidemia

Current atherosclerosis reports, 2018-04, Vol.20 (4), p.17-17, Article 17

2018

Volltextzugriff (PDF)

A Response to: Letter to the Editor Regarding “Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: a Narrative Review”

Advances in therapy, 2020-09, Vol.37 (9), p.4046-4048

2020

Volltextzugriff (PDF)

UPPING THE ANTE ON HEPARIN DOSING: IS IT TIME FOR A CHANGE IN THE MANAGEMENT OF CARDIOVASCULAR PATIENTS IN THE OBESITY ERA?

Journal of the American College of Cardiology, 2016-04, Vol.67 (13), p.533-533

2016

Volltextzugriff (PDF)

Key Articles and Guidelines in the Management of Dyslipidemia: 2019 Update

Journal of pharmacy practice, 2020-12, Vol.33 (6), p.882-894

2020

Volltextzugriff (PDF)

Recommendations for Managing Drug–Drug Interactions with Statins and HIV Medications

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2017-10, Vol.17 (5), p.375-389

2017

Volltextzugriff (PDF)

Discharge Counseling for Patients with Heart Failure or Myocardial Infarction: A Best Practices Model Developed by Members of the American College of Clinical Pharmacy's Cardiology Practice and Research Network Based on the Hospital to Home (H2H) Initiative

Pharmacotherapy, 2013-05, Vol.33 (5), p.558-580

2013

Volltextzugriff (PDF)

Higher Maximum Doses and Infusion Rates Compared with Standard Unfractionated Heparin Therapy Are Associated with Adequate Anticoagulation without Increased Bleeding in Both Obese and Nonobese Patients with Cardiovascular Indications

Pharmacotherapy, 2017-04, Vol.37 (4), p.393-400

2017

Volltextzugriff (PDF)

Postoperative Antibiotic Prophylaxis Following Cardiac Implantable Electronic Device Placement

The Journal of innovations in cardiac rhythm management (Print), 2019-08, Vol.10 (8), p.3777-3784

2019

Volltextzugriff (PDF)

High-Impact Articles Related to the Management of Heart Failure: 2008 Update

Pharmacotherapy, 2009-01, Vol.29 (1), p.82-120

2009

Volltextzugriff (PDF)

EVALUATION OF DIRECT ORAL ANTICOAGULANTS (DOACS) IN PATIENTS WEIGHING GREATER THAN OR EQUAL TO ONE HUNDRED TWENTY KILOGRAMS

Journal of the American College of Cardiology, 2020-03, Vol.75 (11), p.2234-2234

2020

Volltextzugriff (PDF)

2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease

Journal of the American College of Cardiology, 2018-12, Vol.72 (24), p.3200-3223

2018

Volltextzugriff (PDF)

2017 ACC Expert Consensus Decision Pathway for Transcatheter Aortic Valve Replacement in the Management of Adults With Aortic Stenosis: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents

Journal of the American College of Cardiology, 2017-03, Vol.69 (10), p.1313-1346

2017

Volltextzugriff (PDF)

Pharmacotherapy Considerations in Advanced Cardiac Life Support

Pharmacotherapy, 2006-12, Vol.26 (12), p.1703-1729

2006

Volltextzugriff (PDF)

2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways

Journal of the American College of Cardiology, 2018-01, Vol.71 (2), p.201-230

2018

Volltextzugriff (PDF)

1 – 25 von 150

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCatheterization And Cardiovascular Interventions

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(137)
Mit Volltextzugriff
(130)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(149)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Human Angiopoietin-like Protein 3/ANGPTL3 Antibodies: Adding to the Armamentarium in the Management of Dyslipidemia

Select Drug-Drug Interactions With Direct Oral Anticoagulants: JACC Review Topic of the Week

2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee

2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents

Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association

Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care

Select drug-drug interactions with colchicine and cardiovascular medications: A review

Reduced Anticoagulant Effect of Dabigatran in a Patient Receiving Concomitant Phenytoin

2023 Atrial Fibrillation Guideline-at-a-Glance

Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review

Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Weighing ≥ 120 Kilograms versus 60–120 Kilograms

Evolocumab: Considerations for the Management of Hyperlipidemia

A Response to: Letter to the Editor Regarding “Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: a Narrative Review”

UPPING THE ANTE ON HEPARIN DOSING: IS IT TIME FOR A CHANGE IN THE MANAGEMENT OF CARDIOVASCULAR PATIENTS IN THE OBESITY ERA?

Key Articles and Guidelines in the Management of Dyslipidemia: 2019 Update

Recommendations for Managing Drug–Drug Interactions with Statins and HIV Medications

Discharge Counseling for Patients with Heart Failure or Myocardial Infarction: A Best Practices Model Developed by Members of the American College of Clinical Pharmacy's Cardiology Practice and Research Network Based on the Hospital to Home (H2H) Initiative

Higher Maximum Doses and Infusion Rates Compared with Standard Unfractionated Heparin Therapy Are Associated with Adequate Anticoagulation without Increased Bleeding in Both Obese and Nonobese Patients with Cardiovascular Indications

Postoperative Antibiotic Prophylaxis Following Cardiac Implantable Electronic Device Placement

High-Impact Articles Related to the Management of Heart Failure: 2008 Update

EVALUATION OF DIRECT ORAL ANTICOAGULANTS (DOACS) IN PATIENTS WEIGHING GREATER THAN OR EQUAL TO ONE HUNDRED TWENTY KILOGRAMS

2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease

2017 ACC Expert Consensus Decision Pathway for Transcatheter Aortic Valve Replacement in the Management of Adults With Aortic Stenosis: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents

Pharmacotherapy Considerations in Advanced Cardiac Life Support

2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways

Aktive Filter

Suchergebnisse filtern